Robert R. Ruffolo

Insider Reports History

Entity
Individual
Signature
/s/ Robert R. Ruffolo
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert R. Ruffolo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aridis Pharmaceuticals, Inc. Director Restricted Stock Units 10K Dec 5, 2022 Direct
Elicio Therapeutics, Inc. Director Stock Option (right to buy) 4.1K Dec 28, 2023 Direct
Sigilon Therapeutics, Inc. Director Stock Option (Right to Buy) 0 $0.75 Aug 11, 2023 Direct

Insider Reports Filed by Robert R. Ruffolo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELTX Elicio Therapeutics, Inc. Dec 28, 2023 1 $0 4 Dec 29, 2023 Director
SGTX Sigilon Therapeutics, Inc. Aug 11, 2023 3 -$36.1K 4 Aug 11, 2023 Director
ELTX Elicio Therapeutics, Inc. Jun 1, 2023 0 $0 3 Jun 7, 2023 Director
SGTX Sigilon Therapeutics, Inc. May 19, 2023 1 $0 4 May 22, 2023 Director
ARDS Aridis Pharmaceuticals, Inc. Dec 5, 2022 1 $0 4 Dec 7, 2022 Director
SGTX Sigilon Therapeutics, Inc. May 26, 2022 1 $0 4 May 27, 2022 Director
ARDS Aridis Pharmaceuticals, Inc. Oct 4, 2021 1 $0 4 Oct 5, 2021 Director
SGTX Sigilon Therapeutics, Inc. Jul 1, 2021 3 -$66.1K 4 Jul 2, 2021 Director
SGTX Sigilon Therapeutics, Inc. Jun 24, 2021 1 $88.6K 4 Jun 28, 2021 Director